Dexmedetomidine: Increased risk of mortality in intensive care unit (ICU) patients ≤65 years
About
This direct healthcare professional communication (DHPC) contains important information for healthcare professionals prescribing, dispensing or administering the medicine(s). It also includes a communication plan with details of intended recipients and the dissemination date.
Documents
Key facts
Medicine name |
Dexdor
|
Active substance |
Dexmedetomidine hydrochloride
|
Therapeutic area (MeSH) |
Conscious Sedation
|
Procedure number |
EMEA/H/C/002268/II/0035
|
Regulatory outcome |
Maintenance
|
DHPC type |
Safety signal
|
Human ATC code |
N05CM18
|
Dissemination date |
16/06/2022
|